1. Home
  2. FSP vs SER Comparison

FSP vs SER Comparison

Compare FSP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

N/A

Current Price

$0.33

Market Cap

48.2M

Sector

Real Estate

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$2.25

Market Cap

42.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSP
SER
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
42.0M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
FSP
SER
Price
$0.33
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
645.1K
54.9K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
6.34%
N/A
EPS Growth
15.69
N/A
EPS
N/A
N/A
Revenue
$107,162,000.00
$130,000.00
Revenue This Year
$17.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.14
52 Week Low
$0.34
$1.22
52 Week High
$1.71
$5.83

Technical Indicators

Market Signals
Indicator
FSP
SER
Relative Strength Index (RSI) 26.10 45.45
Support Level N/A $1.69
Resistance Level $0.41 $2.95
Average True Range (ATR) 0.02 0.21
MACD -0.01 -0.05
Stochastic Oscillator 0.50 25.86

Price Performance

Historical Comparison
FSP
SER

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: